Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants

Clinical trial NCT00798304 · TERMINATED

Trial details

NCT number: NCT00798304
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Meningitis, Meningococcal

Start date: 2009-01-01
Primary completion: 2009-06-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.